VF
VBIO

Virtu Financial’s Valion Bio VBIO Stock Holding History

Virtu Financial’s Portfolio VBIO Stock Details VBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,232
Closed -$5K – 2049
2024
Q3 		$5K Sell
1,232
-1,238
-50% -$7.48K ﹤0.01% 1249
2024
Q2 		$16K Buy
+2,470
New +$31.1K ﹤0.01% 1061

Other funds holding VBIO

HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Virtu Financial's VBIO Position: Q4 2024 in Review

Virtu Financial sold out of Valion Bio (VBIO) in Q4 2024, closing a stake of 1,232 shares — an estimated $5K sold.

Virtu Financial first reported a position in VBIO in Q2 2024 and held it in 2 quarters. The position peaked at $16K in Q2 2024. 9 funds tracked by Wall St. Rank hold VBIO as of Q4 2024.

  • Virtu Financial reported no remaining Valion Bio position as of Q4 2024 after selling out during the quarter.
  • Virtu Financial sold 1,232 Valion Bio shares in Q4 2024, an estimated $5K.
  • Virtu Financial first reported a position in Valion Bio in Q2 2024 and held it in 2 quarters.
  • Virtu Financial's Valion Bio position peaked at $16K in Q2 2024.
  • 9 funds tracked by Wall St. Rank held Valion Bio as of Q4 2024.

Based on Virtu Financial's 13F filing for Q4 2024, filed 11 Feb 2025.